No headlines found.
Sabra Health Care REIT, Inc. to Attend the 2026 NIC Spring Conference
Business Wire (Mon, 16-Mar 4:05 PM ET)
Sabra Health Care REIT, Inc. to Participate in Deutsche Bank's 2026 Healthcare REIT Summit
Business Wire (Tue, 10-Mar 4:05 PM ET)
Globe Newswire (Mon, 23-Feb 8:30 AM ET)
Sabra Health Care REIT, Inc. to Attend Citi's 2026 Global Property CEO Conference
Business Wire (Fri, 13-Feb 4:05 PM ET)
Sabra Reports Fourth Quarter 2025 Results; Introduces 2026 Guidance
Business Wire (Thu, 12-Feb 4:05 PM ET)
Business Wire (Mon, 2-Feb 4:05 PM ET)
Sabra Health Care REIT, Inc. Announces Tax Treatment of 2025 Distributions
Business Wire (Mon, 26-Jan 9:05 AM ET)
Business Wire (Mon, 5-Jan 9:15 AM ET)
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.
Sabra Health Care REIT trades on the NASDAQ stock market under the symbol SBRA.
As of April 1, 2026, SBRA stock price climbed to $19.34 with 476,782 million shares trading.
SBRA has a beta of 0.00, meaning it tends to be less sensitive to market movements. SBRA has a correlation of 0.00 to the broad based SPY ETF.
SBRA has a market cap of $4.88 billion. This is considered a Mid Cap stock.
Last quarter Sabra Health Care REIT reported $212 million in Revenue and $.36 earnings per share. This beat revenue expectation by $12 million and exceeded earnings estimates by $.11.
In the last 3 years, SBRA traded as high as $21.07 and as low as $10.30.
The top ETF exchange traded funds that SBRA belongs to (by Net Assets): VNQ, VTI, IJH, IWM, VB.
SBRA has underperformed the market in the last year with a price return of +17.6% while the SPY ETF gained +18.8%. However, in the short term, SBRA had mixed performance relative to the market. It has outperformed in the last 3 months, returning +3.7% vs -3.4% return in SPY. But in the last 2 weeks, SBRA shares have been beat by the market, returning -6.8% compared to an SPY return of -1.8%.
SBRA support price is $18.93 and resistance is $19.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SBRA shares will trade within this expected range on the day.